» Articles » PMID: 38098662

High Risk HPV-positive Women Cervicovaginal Microbial Profiles in a Greek Cohort: a Retrospective Analysis of the GRECOSELF Study

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2023 Dec 15
PMID 38098662
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence supports a role for the vaginal microbiome (VM) in the severity of HPV infection and its potential link to cervical intraepithelial neoplasia. However, a lot remains unclear regarding the precise role of certain bacteria in the context of HPV positivity and persistence of infection. Here, using next generation sequencing (NGS), we comprehensively profiled the VM in a series of 877 women who tested positive for at least one high risk HPV (hrHPV) type with the COBAS 4,800 assay, after self-collection of a cervico-vaginal sample. Starting from gDNA, we PCR amplified the V3-V4 region of the bacterial 16S rRNA gene and applied a paired-end NGS protocol (Illumina). We report significant differences in the abundance of certain bacteria compared among different HPV-types, more particularly concerning species assigned to and genera. Especially for , we observed significant depletion in the case of HPV16, HPV18 versus hrHPVother. Overall, our results suggest that the presence or absence of specific cervicovaginal microbial genera may be linked to the observed severity in hrHPV infection, particularly in the case of HPV16, 18 types.

References
1.
Brotman R, Shardell M, Gajer P, Tracy J, Zenilman J, Ravel J . Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014; 210(11):1723-33. PMC: 4296189. DOI: 10.1093/infdis/jiu330. View

2.
Caselli E, DAccolti M, Santi E, Soffritti I, Conzadori S, Mazzacane S . Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study. Front Cell Infect Microbiol. 2020; 10:540900. PMC: 7676899. DOI: 10.3389/fcimb.2020.540900. View

3.
Munoz N, Bosch F, Castellsague X, Diaz M, de Sanjose S, Hammouda D . Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004; 111(2):278-85. DOI: 10.1002/ijc.20244. View

4.
Curty G, de Carvalho P, Soares M . The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer. Int J Mol Sci. 2020; 21(1). PMC: 6981542. DOI: 10.3390/ijms21010222. View

5.
Lebeau A, Bruyere D, Roncarati P, Peixoto P, Hervouet E, Cobraiville G . HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nat Commun. 2022; 13(1):1076. PMC: 8885657. DOI: 10.1038/s41467-022-28724-8. View